First Time Loading...

Inhibrx Inc
NASDAQ:INBX

Watchlist Manager
Inhibrx Inc Logo
Inhibrx Inc
NASDAQ:INBX
Watchlist
Price: 34.04 USD -0.35% Market Closed
Updated: May 1, 2024

Inhibrx Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inhibrx Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Inhibrx Inc
NASDAQ:INBX
Revenue
$1.8m
CAGR 3-Years
-48%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

Inhibrx Inc
Revenue Breakdown

Breakdown by Geography
Inhibrx Inc

Not Available

Breakdown by Segments
Inhibrx Inc

Total Revenue: 1.8m USD
100%
License Fee Revenue: 1.8m USD
100%

See Also

What is Inhibrx Inc's Revenue?
Revenue
1.8m USD

Based on the financial report for Dec 31, 2023, Inhibrx Inc's Revenue amounts to 1.8m USD.

What is Inhibrx Inc's Revenue growth rate?
Revenue CAGR 5Y
-27%

Over the last year, the Revenue growth was -18%. The average annual Revenue growth rates for Inhibrx Inc have been -48% over the past three years , -27% over the past five years .